21 August, 2016 by The TZ Newswire Staff Comments Off on Fed’s Fischer: "We are close to our targets"
Fed’s Fischer: "We are close to our targets"
Federal Reserve Vice Chairman Stanley Fischer in a speech in Colorado
Fischer took a somewhat hawkish tone in a speech in Aspen, Colorado but probably not enough to support the dollar when the market re-opens.
21 August, 2016 by The TZ Newswire Staff Comments Off on Economic Preview: U.S. economy providing ammo for higher interest rates
Economic Preview: U.S. economy providing ammo for higher interest rates
As the dog days of summer draw to a close, the economy appears primed for somewhat faster growth in the second half of the year that’s likely to pave the way for higher U.S.
21 August, 2016 by The TZ Newswire Staff Comments Off on NewsWatch: Here’s the safest place for your money with stocks near record highs
NewsWatch: Here’s the safest place for your money with stocks near record highs
U.S.
21 August, 2016 by The TZ Newswire Staff Comments Off on Alice Friedemann: When The Trucks Stop Running
Alice Friedemann: When The Trucks Stop Running
Alice Friedemann is a transportation expert sounding the alarm on the unsustainable nature of our modern trucking system, which is critical for delivering goods where they need to be, when they need to be, in our just-in-time economy.
21 August, 2016 by The TZ Newswire Staff Comments Off on Oil Rally At Risk After Niger Delta Advisors Announce Ceasefire
Oil Rally At Risk After Niger Delta Advisors Announce Ceasefire
Three months ago, we introduced reaeders to the Niger Delta Avengers (the NDA): a mysterious Nigerian militant group, which appeared out of nowhere, and which as we said at the time, “held the price of oil in its their hands”, as a result of its relentless – and successful – attempts to sabotage Nigerian oil production. Back in May, the NDA was cit
21 August, 2016 by The TZ Newswire Staff Comments Off on How Would Hillary Clinton Change Gun Rights?
How Would Hillary Clinton Change Gun Rights?
21 August, 2016 by The TZ Newswire Staff Comments Off on 3 Reasons Medivation Is the Juiciest Target in Biotech
3 Reasons Medivation Is the Juiciest Target in Biotech
When the going gets tough, the tough go shopping — especially when the tough run a major drug company. And given how many big pharmas are facing serious patent losses, it’s no surprise that seemingly half of the world’s drug companies are rumored to be falling all over themselves to snap up cancer-focused biotech Medivation (NASDAQ: MDVN).